Gifford Fong Associates Abb Vie Inc. Transaction History
Gifford Fong Associates
- $400 Million
- Q3 2024
A detailed history of Gifford Fong Associates transactions in Abb Vie Inc. stock. As of the latest transaction made, Gifford Fong Associates holds 27,900 shares of ABBV stock, worth $5.13 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
27,900
Previous 27,900
-0.0%
Holding current value
$5.13 Million
Previous $4.79 Million
15.15%
% of portfolio
1.38%
Previous 1.27%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
3,891Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$31.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.62 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.12 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $325B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...